Romanth Waghmarae
Pain Medicine · Hamburg, NYNPI 1174530299
Payments from drug & device makers
Across 1,397 payments — averaging $113.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$43K
- Scilex Pharmaceuticals Inc.$26K
- GRT US Holding, Inc.$18K
- Medtronic$17K
- Daiichi Sankyo Inc.$15K
- SPR Therapeutics, Inc$6K
- plus $32K from 54 others
Across 4 payments — averaging $720.42 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Boston Scientific$3K
What the payments were for
- Consulting fees$9,1006%
- Speaking & faculty fees$89,08456%
- Travel & lodging$24,77616%
- Food & beverage$35,25322%
- Education$1060%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ZTLido$25,594
- SPECTRA WAVEWRITER$24,463
- Qutenza$17,190
- Morphabond ER$14,691
- INTELLIS ADAPTIVESTIM$11,887
- GENERAL PAIN MANAGEMENT$8,372
- GENERAL - THERAPIES$5,461
- SPRINT PNS System$5,320
- VANTA ADAPTIVESTIM$2,303
- Evoke$2,169
- Superion ISS$1,665
- PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A$1,315
- ADAPTIVESTIM$1,137
- HA MINUTEMAN G3-R$1,135
- InSpan$1,007
- SacroFuse$1,007
- NanoFuse Putty$1,007
- Senza$994
- AIMOVIG$915
- Roxybond$882
How this compares
$158,318 in reported general payments places this provider in the 95th percentile of 503 pain medicine providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BelbucaBuprenorphine Hcl | 85 | $56,815 |
| Buprenorphine | 179 | $46,821 |
| NucyntaTapentadol Hcl | 66 | $43,811 |
| Nucynta ErTapentadol Hcl | 65 | $38,838 |
| Xtampza ErOxycodone Myristate | 52 | $30,622 |
| HorizantGabapentin Enacarbil | 14 | $9,346 |
| MovantikNaloxegol Oxalate | 16 | $7,031 |
| OxycontinOxycodone Hcl | 18 | $7,001 |
| ButransBuprenorphine | 11 | $5,153 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 264 | $4,556 |
| Pregabalin | 140 | $2,845 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 167 | $2,612 |
| Baclofen | 190 | $2,310 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 18 | $2,269 |
| Tramadol Hcl ErTramadol Hcl | 43 | $1,928 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Belbuca, Nucynta, Nucynta Er, Xtampza Er | $1,378 | $170,086268 claims |
| Arbor Pharmaceuticals, Inc.Horizant | $211 | $9,34614 claims |
| Redhill Biopharma Inc.Movantik | $39 | $7,03116 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 503 pain medicine providers in New York.
Other pain medicine in Hamburg
- Gary SchwartzBrooklyn$756K
- Amitabh GulatiNew York$627K
- William CaldwellStony Brook$550K
- Brian DurkinPort Jefferson$459K
- Grace FordeNew Hyde Park$398K
- David SpinnerNew York$391K
- John MarkmanRochester$300K
- Naum ShaparinBronx$178K
- Ashraf HenryAmherst$168K
- Kenneth ChapmanStaten Island$160K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.